• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

米多君，一种口服α-1 肾上腺素能受体激动剂，成功治疗新生儿难治性先天性乳糜性胸腔积液和腹水。

Midodrine, an Oral Alpha-1 Adrenoreceptor Agonist, Successfully Treated Refractory Congenital Chylous Pleural Effusion and Ascites in a Neonate.

机构信息

Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

出版信息

Chest. 2021 Apr;159(4):e189-e191. doi: 10.1016/j.chest.2020.10.071. Epub 2021 Apr 6.

DOI:10.1016/j.chest.2020.10.071
PMID:34022016
Abstract

A trisomy 21 neonate presented with congenital chylous pleural effusion and ascites that was refractory to conventional pharmacotherapy. Midodrine, an oral alpha-1-adrenoreceptor agonist, achieved remission of chylous effusion without any adverse effects. To the best of our knowledge, this is the first neonatal case of successful management of congenital chylous pleural effusion and ascites with midodrine.

摘要

一名 21 三体综合征新生儿出现先天性乳糜性胸腔积液和腹水，对常规药物治疗无反应。米多君，一种口服的α-1 肾上腺素能受体激动剂，成功地缓解了乳糜性渗出液，没有任何不良反应。据我们所知，这是首例使用米多君成功治疗先天性乳糜性胸腔积液和腹水的新生儿病例。

相似文献

1
Midodrine, an Oral Alpha-1 Adrenoreceptor Agonist, Successfully Treated Refractory Congenital Chylous Pleural Effusion and Ascites in a Neonate.米多君，一种口服α-1 肾上腺素能受体激动剂，成功治疗新生儿难治性先天性乳糜性胸腔积液和腹水。
Chest. 2021 Apr;159(4):e189-e191. doi: 10.1016/j.chest.2020.10.071. Epub 2021 Apr 6.
2
Use of an Alpha-1 Adrenoreceptor Agonist in the Management of Recurrent Refractory Idiopathic Chylothorax.采用α1 肾上腺素受体激动剂治疗复发性难治性特发性乳糜胸。
Chest. 2018 Jul;154(1):e1-e4. doi: 10.1016/j.chest.2018.02.005.
3
Use of Propranolol in the Treatment of Chylous Effusions in Infants.普萘洛尔在婴儿乳糜性胸腔积液治疗中的应用。
Pediatrics. 2021 Jul;148(1). doi: 10.1542/peds.2020-049699. Epub 2021 Jun 29.
4
OK-432 therapy for chylous pleural effusion or ascites associated with lymphatic malformations.OK-432 疗法治疗淋巴管畸形相关乳糜性胸腔积液或腹水。
J Pediatr Surg. 2010 Sep;45(9):e7-10. doi: 10.1016/j.jpedsurg.2010.06.010.
5
Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis.西罗莫司联合奥曲肽治疗可减少西罗莫司难治性乳糜性胸腔积液合并淋巴管平滑肌瘤病。
Intern Med. 2017 Dec 15;56(24):3327-3331. doi: 10.2169/internalmedicine.8645-16. Epub 2017 Oct 11.
6
Correction to dosage in text and figure: Midodrine, an Oral Alpha-1 Adrenoreceptor Agonist, Successfully Treated Refractory Congenital Chylous Pleural Effusion and Ascites in a Neonate.
Chest. 2022 Feb;161(2):590. doi: 10.1016/j.chest.2022.01.001.
7
Heparin in Congenital Chylothorax and Chylous Ascites.肝素在先天性乳糜胸和乳糜腹水中的应用。
Indian J Pediatr. 2019 Jul;86(7):660-661. doi: 10.1007/s12098-019-02956-x. Epub 2019 Apr 22.
8
Congenital Chylothorax: Common and Uncommon Findings in an Infant with Chylous Effusions.先天性乳糜胸：一例乳糜性胸腔积液婴儿的常见及罕见表现
Neonatal Netw. 2019 Nov 1;38(6):357-364. doi: 10.1891/0730-0832.38.6.357.
9
Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective study.先天性胎儿和新生儿内脏乳糜性积液：新生儿乳糜胸和乳糜性腹水再探。一项多中心回顾性研究。
Lymphology. 2012 Sep;45(3):91-102.
10
Antithrombin activity in children with chylothorax.乳糜胸患儿的抗凝血酶活性
Eur J Cardiothorac Surg. 2006 Mar;29(3):406-9. doi: 10.1016/j.ejcts.2005.12.015. Epub 2006 Jan 24.

引用本文的文献

1
Clinical features and outcomes of congenital chylothorax: a single tertiary medical center experience in China.先天性乳糜胸的临床特征和结局：中国一家三级医学中心的单中心经验。
J Cardiothorac Surg. 2022 Oct 27;17(1):276. doi: 10.1186/s13019-022-02009-z.